Micromem Technologies Inc.
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsMicromem Technologies Inc. is a development-stage, pre-revenue technology company that funds operations through convertible debentures and holds patents related to sensor and memory technologies.
What they do
The filing excerpt provides no narrative description of the company's actual operations or products. The tagging identifies it as a computer programming services company (SIC 8442) reporting under IFRS with a fiscal year ended October 31. The only asset detail visible in the source material is a patent asset class, and the only liability detail is USD- and CAD-denominated convertible debentures with embedded derivatives and equity components.
Revenue drivers
- No revenue-generating segment disclosed — The source material contains no revenue line items, segment tables, or product-level sales data for any period presented.
- Patent asset — The filing tags a patent asset at gross carrying amount with accumulated amortisation for FY2025, FY2024 and FY2023, but no licensing or sale revenue is disclosed.
- Convertible debenture financing — USD- and CAD-denominated convertible debentures with embedded derivatives are tagged as the principal liability and financing instrument; this is capital raising, not revenue.
- Not determinable from provided excerpts — With no business description text and no income statement detail beyond expense categories, the company's revenue sources cannot be identified from this source.
Recent performance
The provided excerpts contain no income statement figures, balance sheet figures, or cash flow figures. Operating cost categories tagged for FY2025, FY2024 and FY2023 include general and administrative, rent and occupancy, office insurance, investor relations/listing and filing fees, professional fees, consulting fees, salaries and benefits, and telephone. The only reliably identifiable financial features are a patent asset class and USD- and CAD-denominated convertible debentures with embedded derivatives and, for the USD instruments, equity components. No net income or loss, asset total, or cash balance is disclosed in the source material, so period-over-period performance cannot be assessed.
Strategy
The source material does not contain management's discussion and analysis narrative, so no stated strategy can be quoted. The tagged expense structure (general and administrative, professional fees, consulting fees, investor relations and filing fees) and the presence of convertible debenture financing indicate a company sustaining itself through external capital rather than operating cash flow. The tagged patent asset suggests some continued carrying of intellectual property, but no development, commercialisation or partnership programme is described in the excerpt. Financing activity in subsequent events is tagged across convertible debentures, warrants, directors/officers/employees and related parties, indicating continued reliance on related-party and convertible funding. No forward-looking capital plan, product roadmap, or milestone is disclosed in the source material.
Risks
- No disclosed revenue — No revenue line item appears anywhere in the provided excerpts, leaving the company dependent on financing to fund operations.
- Convertible debenture dilution and derivative exposure — Multiple USD- and CAD-denominated convertible debentures with embedded derivatives and equity components are tagged, creating conversion, valuation and fair-value volatility exposure.
- Related-party financing — Subsequent events tags include related parties and directors, officers and employees alongside convertible debentures and warrants, indicating dependence on insiders for capital.
- Liquidity and currency risk — IFRS liquidity risk and currency risk disclosures are tagged for FY2024 and FY2025, consistent with obligations denominated in both USD and CAD.
Outlook
The source material contains no management outlook, guidance or forward-looking statement that can be quoted. The tagged subsequent events involving convertible debentures, warrants, related parties and directors/officers/employees indicate financing activity after the October 31, 2025 balance sheet date. No statements about future products, revenue, partnerships or profitability are present in the provided excerpts.